Chemed Corp (CHE) Earnings: 1Q Adjusted EPS Surpasses Estimates with Strong Revenue Growth

Chemed Corp on Smartkarma

Analyst coverage of Chemed Corp on Smartkarma reveals a diverse outlook on the company’s recent financial performance. Baptista Research‘s report titled “Chemed Corporation: The Covenant Health Acquisition Is A Game-Changing Move!” highlights a positive sentiment, emphasizing the strong operating performance of Chemed’s hospice segment, VITAS Healthcare. The acquisition of Covenant Health significantly contributed to VITAS’s growth, with admissions and average daily census showing substantial increases.

Another report by Baptista Research, “Chemed Corporation: How Is The Management Tackling Roto-Rooter Challenges & Other Risks? -Major Drivers,” presents a more nuanced view. It notes mixed performance in the third quarter of 2024, with VITAS Healthcare demonstrating strength while the plumbing business, Roto-Rooter, faces challenges. Despite Roto-Rooter’s struggles, VITAS’s growth, boosted by acquisitions like Covenant Health, underscores Chemed Corp‘s strategic moves and potential for future success.

A look at Chemed Corp Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts on Smartkarma have given Chemed Corp a positive long-term outlook, with high scores in Growth, Resilience, and Momentum. These scores indicate that the company is expected to experience strong growth, show resilience during challenging market conditions, and have good momentum for future success. While the Value and Dividend scores are not as high, the overall outlook for Chemed Corp remains optimistic.

Chemed Corporation, known for its subsidiaries Vitas Healthcare Corporation, Roto-Rooter, and Service America Network Inc, has received favorable ratings indicating potential for growth and stability in the healthcare and repair-and-maintenance-service industries. With a focus on growth, resilience, and momentum, Chemed Corp seems well-positioned for long-term success in its diverse business segments.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma